Donanemab | Patient undergoes infusion
Media Contact: Susan Gregg - 206-390-3226, sghanson@uw.edu
UW Medicine patient Bob Pringle, 76, of Woodinville, Washington, receives intravenous donanemab to treat Alzheimer's disease in April 2025 at Harborview Medical Center in Seattle. See associated news release.